UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences

Higher Education / Graduate Biomedical Sciencesgsbs.uth.edu

Joint graduate school administered by MD Anderson Cancer Center and UTHealth Houston in the Texas Medical Center, offering PhD, MS, and MD/PhD programs in biomedical sciences to prospective students pursuing research careers.

Company typePublic
Founded-
HeadquartersHouston, United States
Headcount251–500
GTM typeB2C
OfferingServices

What UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences does

The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences (GSBS) is a public graduate school jointly administered by MD Anderson Cancer Center and UTHealth Houston, located within the Texas Medical Center in Houston. It offers PhD programs across nine specializations (Cancer Biology, Genetics & Epigenetics, Immunology, Microbiology & Infectious Diseases, Molecular & Translational Biology, Neuroscience, Quantitative Sciences, Therapeutics & Pharmacology, plus Medical Physics), specialized MS programs in Genetic Counseling and Medical Physics, an Individualized MS in Biomedical Sciences, and a combined MD/PhD program delivered with McGovern Medical School, MD Anderson, and the Center for Clinical Translational Sciences.

The school draws on more than 600 faculty from both parent institutions and supports an annual research expenditure base exceeding $476 million, placing the combined MD Anderson–UTHealth Houston enterprise 25th among NIH-funded institutions. Its facilities include classrooms, conference rooms, a computer lab, and the Schissler Library within the Mitchell Basic Sciences Research Building (BSRB) at MD Anderson, with IT-supported distance learning and video conferencing across Microsoft Teams, Zoom, WebEx, and Polycom/Cisco Spark. Notable affiliated research includes BetaBart, a first-in-class B7-H3 antibody radio-theranostic using Lutetium-177, developed in partnership with Radiopharm Theranostics and currently in Phase I/II clinical trial (NCT07189871).

GSBS generates revenue through tuition and fees (governed by UTHealth and UT System policies), research grants and sponsored programs (NIH and federal funding routed largely through parent institutions), and institutional support from MD Anderson and UTHealth Houston. Admissions are managed through the ApplyUTH and myUTH portals, with recruitment across national and international student pools and financial assistance via fellowships, scholarships, and assistantships. The student body is distributed across multiple PhD and MS programs — for example, the Cancer Biology Program enrolls approximately 70 students with 120 affiliated faculty, and the Genetics & Epigenetics Program enrolls roughly 50 students.

UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences firmographics

Firmographics

Name: UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences
Legal name: The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences
Website: https://gsbs.uth.edu
Company type: Public
Operating status: Operating
Headcount range: 251–500 employees
Short description: Joint graduate school administered by MD Anderson Cancer Center and UTHealth Houston in the Texas Medical Center, offering PhD, MS, and MD/PhD programs in biomedical sciences to prospective students pursuing research careers.
Ownership category
akta.pro rank

UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences industry classification

Industry

Product category: Higher Education / Graduate Biomedical Sciences
NAICS: Colleges, Universities, and Professional Schools (6113), Scientific Research and Development Services (5417)
SIC: Services-Educational Services (8200), Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry: Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)
akta.pro secondary industry: Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC)

Keywords

Biomedical research education
Graduate school programs
Phd biomedical sciences
Cancer biology research
Medical physics training

Where UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences is headquartered

Location

Headquarters

HQ city: Houston
HQ country: United States
HQ region: North America

Offices8 records

Markets served

UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences business model

Business model

GTM type: B2C
Offering type: Services
Cost components: Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Others

Revenue model

Tuition and Fees: Graduate school generates revenue through tuition and fees charged to enrolled PhD, MS, and MD/PhD students. Financial assistance including fellowships, scholarships, and assistantships are available.
Research Grants and Sponsored Programs: Faculty research expenditures totaled over $476 million. Combined, UTHealth Houston and MD Anderson rank 25th among NIH research-funded institutions. Federal and institutional grant funding supports the school's research enterprise.
Institutional Support: Administered by MD Anderson Cancer Center and UTHealth Houston, receiving institutional funding and support from both parent organizations and the broader Texas Medical Center ecosystem.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels9 records

UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences product offering

Product offering

Core offering

The Graduate School of Biomedical Sciences (GSBS) is a joint graduate school administered by MD Anderson Cancer Center and UTHealth Houston, offering PhD, MS, and MD/PhD degree programs in biomedical sciences including Cancer Biology, Genetics & Epigenetics, Immunology, Microbiology & Infectious Diseases, Molecular & Translational Biology, Neuroscience, Quantitative Sciences, Therapeutics & Pharmacology, Medical Physics, and Genetic Counseling. The institution delivers doctoral and master's research training through coursework, mentored research, and access to Texas Medical Center facilities, supported by over 600 faculty members and more than $476 million in research expenditures.

Product overview

The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences is a collaborative graduate education institution administered by MD Anderson Cancer Center and UTHealth Houston, offering PhD programs (Cancer Biology, Genetics & Epigenetics, Immunology, Microbiology & Infectious Diseases, Molecular & Translational Biology, Neuroscience, Quantitative Sciences, Therapeutics & Pharmacology), MS programs (Thesis Based, Genetic Counseling, Medical Physics, Individualized MS in Biomedical Sciences), and MD/PhD programs. The school provides research training with over 600 faculty members and research expenditures exceeding $476 million, ranked 25th among NIH-funded institutions. Located in the Texas Medical Center, the institution supports students through IT services, career development, student wellness programs, and specialized research facilities including access to TMC Library and MD Anderson Research Medical Library.

Differentiator

Problem solved

Functional benefit

Products and services

PhD Programs in Biomedical Sciences

Quantifiable outcome

Research expenditures exceeding $476 million from faculty
+2 more outcomes

Companies that use UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles2 records

UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences technology and API

Technology

Technology focussed No

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Integration14 records

Feature3 records

UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered minor and core.

UT Austin (The University of Texas at Austin)minorStrategic or Co-development Partner · 21 April 2026MD Anderson Cancer Center will be fully integrated into UT Austin's new campus to deliver coordinated oncology care as part of the UT Dell Medical Center project — a comprehensive tech-native academic medical center backed by a $750M gift from Michael and Susan Dell.
Radiopharm Theranostics / Radiopharm Ventures, LLCcoreStrategic or Co-development Partner · 1 April 2025GSBS researchers developed a first-in-class B7-H3 antibody radio-theranostic (BetaBart) through a partnership with Radiopharm Theranostics via Radiopharm Ventures, LLC. The partnership enabled advancement of the investigational drug into Phase I/II clinical trial (NCT07189871) following promising preclinical results showing tumor shrinkage and immune memory initiation.
MD Anderson Cancer CentercoreStrategic or Co-development PartnerMD Anderson Cancer Center is one of the two parent institutions administering GSBS. Faculty, classrooms, and laboratories are drawn from MD Anderson, providing cancer research expertise and clinical resources. Both MD Anderson and UTHealth Houston are accredited by SACSCOC.
UTHealth Houston (The University of Texas Health Science Center at Houston)coreStrategic or Co-development PartnerUTHealth Houston is one of the two parent institutions administering GSBS. Faculty, classrooms, and laboratories are drawn from UTHealth Houston, including McGovern Medical School, School of Public Health, School of Dentistry, and School of Biomedical Informatics. Combined with MD Anderson, UTHealth Houston ranks 25th among NIH research-funded institutions.
McGovern Medical SchoolcoreStrategic or Co-development PartnerMcGovern Medical School is a key UTHealth Houston entity participating in the MD/PhD program alongside GSBS, MD Anderson Cancer Center, and the Center for Clinical Translational Sciences.
Center for Clinical Translational Sciences (CCTS)minorStrategic or Co-development PartnerCCTS participates in the MD/PhD program alongside GSBS, MD Anderson Cancer Center, and McGovern Medical School, supporting translational research training.
The Texas Medical Center (TMC)coreOthersGSBS is located in The Texas Medical Center — the world's largest medical center with 61 institutions, 106,000 employees, and over 160,000 daily visitors. This ecosystem provides GSBS students with access to boundless scientific resources and expertise across institutions.
Southern Association of Colleges and Schools Commission on Colleges (SACSCOC)minorOthersBoth MD Anderson and UTHealth Houston are accredited by SACSCOC, the regional accreditor for institutions in the southern United States.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences compliance and trust

Trust signal

Compliance3 records

UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences leadership team

Management profile

Number of profiles

Profiles15 records

UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences

What does UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences do?

Is UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences a public or private company?

UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences is a public company. It is classified as state government owned and is currently operating.

When was UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences founded?

UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences was founded in -1. It employs 251 to 500 people.

Where is UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences based?

UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences is headquartered in Houston, United States, in the North America region.

How does UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences make money?

Three revenue lines are on record. Tuition and Fees are the primary driver. The others are research Grants and Sponsored Programs and institutional Support.

Does UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences have an API?

No public API is recorded for UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences.

What industry is UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences in?

UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences's product category is Higher Education / Graduate Biomedical Sciences. Its primary akta.pro industry code is EDAHAGAI, Biomedical Sciences & Medical Research Institutes (University-Based), with a secondary code of EDAHAAAC, Public Research Universities with Academic Medical Centers (AMCs). Its NAICS code is 6113 and its SIC code is 8200.